These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9789161)

  • 1. Psychiatric comorbidity in methadone maintained patients.
    Mason BJ; Kocsis JH; Melia D; Khuri ET; Sweeney J; Wells A; Borg L; Millman RB; Kreek MJ
    J Addict Dis; 1998; 17(3):75-89. PubMed ID: 9789161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
    Schäfer I; Eiroa-Orosa FJ; Verthein U; Dilg C; Haasen C; Reimer J
    Psychopathology; 2010; 43(2):88-95. PubMed ID: 20068379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment.
    Astals M; Domingo-Salvany A; Buenaventura CC; Tato J; Vazquez JM; Martín-Santos R; Torrens M
    Subst Use Misuse; 2008; 43(5):612-32. PubMed ID: 18393080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).
    Maremmani I; Pacini M; Lubrano S; Perugi G; Tagliamonte A; Pani PP; Gerra G; Shinderman M
    Eur Addict Res; 2008; 14(3):134-42. PubMed ID: 18552489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity.
    Maremmani I; Zolesi O; Aglietti M; Marini G; Tagliamonte A; Shinderman M; Maxwell S
    J Addict Dis; 2000; 19(2):29-41. PubMed ID: 10809518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
    Ngo HT; Tait RJ; Hulse GK
    J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan.
    Chiang SC; Chan HY; Chang YY; Sun HJ; Chen WJ; Chen CK
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):105-11. PubMed ID: 17239047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
    Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
    Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders.
    Carrà G; Scioli R; Monti MC; Marinoni A
    Eur Addict Res; 2006; 12(2):96-101. PubMed ID: 16543745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
    Frei A; Rehm J;
    Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of psychiatric symptoms among drug misusers after drug dependence treatment.
    Gossop M; Marsden J; Stewart D
    J Nerv Ment Dis; 2006 Nov; 194(11):826-32. PubMed ID: 17102706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of psychopathology in drug-addicted Dutch.
    von Limbeek J; Wouters L; Kaplan CD; Geerlings PJ; von Alem V
    J Subst Abuse Treat; 1992; 9(1):43-52. PubMed ID: 1317465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients.
    Carpentier PJ; Krabbe PF; van Gogh MT; Knapen LJ; Buitelaar JK; de Jong CA
    Am J Addict; 2009; 18(6):470-80. PubMed ID: 19874168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar II and unipolar comorbidity in 153 outpatients with social phobia.
    Perugi G; Frare F; Toni C; Mata B; Akiskal HS
    Compr Psychiatry; 2001; 42(5):375-81. PubMed ID: 11559864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for psychopathology in the clinical practice.
    Eland-Goossensen A; van de Goor I; Garretsen H; Schudel J
    J Subst Abuse Treat; 1997; 14(6):585-91. PubMed ID: 9437632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.